Search Results

Displaying Results 1-1 of 1 "'NBTX'"
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
Novel Cancer Platforms Converge as Clinical Data Reshapes Treatment Paradigms

Oct 07, 2025, 08:00 ET Novel Cancer Platforms Converge as Clinical Data Reshapes Treatment Paradigms

I-Mab (NASDAQ: IMAB), enGene Holdings Inc. (NASDAQ: ENGN), Onconetix, Inc. (NASDAQ: ONCO), and Nanobiotix S.A. (NASDAQ: NBTX).

More news about: Equity Insider

Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.